Looking to reinvigorate itself, Block Drug Company has retained the services of Goldman Sachs to explore strategic alternatives, including a possible sale or merger. The June 6 announcement caught fire with the Street. Block’s stock price went up $12.50 before closing at $39.88. At press time, it closed at $42.56.
To read the entire story, you must be logged in.
Please log in now or register with us.
